A Randomised, Double-blind, Placebo-controlled Study
DescriptionA forum to discuss or ask questions about a Randomised, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of the H3 Receptor Antagonist, GSK239512 in Subjects with Mild to Moderate Alzheimer's Disease.
